home / stock / pbyi / pbyi quote
Last: | $4.88 |
---|---|
Change Percent: | 1.04% |
Open: | $4.78 |
Close: | $4.88 |
High: | $5.06 |
Low: | $4.72 |
Volume: | 231,224 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.88 | $4.78 | $4.88 | $5.06 | $4.72 | 231,224 | 04-25-2024 |
$4.83 | $5.09 | $4.83 | $5.135 | $4.77 | 309,785 | 04-24-2024 |
$5.13 | $5.17 | $5.13 | $5.34 | $5.1 | 293,766 | 04-23-2024 |
$5.17 | $5.01 | $5.17 | $5.27 | $5 | 265,410 | 04-22-2024 |
$5.01 | $4.92 | $5.01 | $5.08 | $4.9 | 290,457 | 04-19-2024 |
$4.99 | $5.18 | $4.99 | $5.29 | $4.925 | 289,054 | 04-18-2024 |
$5.17 | $5.1 | $5.17 | $5.3 | $5.05 | 248,185 | 04-17-2024 |
$5.1 | $5.32 | $5.1 | $5.42 | $5.06 | 285,862 | 04-16-2024 |
$5.35 | $5.3 | $5.35 | $5.43 | $5.25 | 266,547 | 04-15-2024 |
$5.27 | $5.37 | $5.27 | $5.5206 | $5.212 | 221,709 | 04-12-2024 |
$5.49 | $5.51 | $5.49 | $5.65 | $5.46 | 145,931 | 04-11-2024 |
$5.525 | $5.77 | $5.525 | $5.8 | $5.4 | 378,662 | 04-10-2024 |
$5.83 | $5.61 | $5.83 | $6.055 | $5.59 | 552,103 | 04-09-2024 |
$5.63 | $5.64 | $5.63 | $5.71 | $5.44 | 315,266 | 04-08-2024 |
$5.66 | $5.49 | $5.66 | $5.84 | $5.42 | 405,403 | 04-05-2024 |
$5.51 | $5.4 | $5.51 | $5.57 | $5.36 | 530,286 | 04-04-2024 |
$5.35 | $5.24 | $5.35 | $5.35 | $5.1 | 337,167 | 04-03-2024 |
$5.28 | $5.16 | $5.28 | $5.33 | $5.05 | 375,493 | 04-02-2024 |
$5.28 | $5.42 | $5.28 | $5.42 | $5.12 | 400,922 | 04-01-2024 |
$5.3 | $5.56 | $5.3 | $5.6 | $5.2425 | 275,380 | 03-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
Puma Biotechnology Inc Company Name:
PBYI Stock Symbol:
NASDAQ Market:
Puma Biotechnology Inc Website:
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, will host a conference call at 1:30 p.m. PDT/4:30 p.m. EDT on Thursday, May 2, 2024, following the release of its first quarter 2024 financial results. The call may be accessed by dialing 1-877-709-8150 (domestic) or 1-201-...
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company (the Company), has been notified by the U.S. Food and Drug Administration (FDA) that its Investigational New Drug Application (IND) submission has been reviewed, and Puma can proceed with the clinical development of alisertib fo...
Evolv Technologies Holdings Inc. (EVLV) is expected to report $-0.14 for Q4 2023 The Lion Electric Company (LEV) is expected to report $-0.1 for Q4 2023 Fisker Inc. Class A (FSR) is expected to report $-0.2 for Q4 2023 Y-mAbs Therapeutics Inc. (YMAB) is expected to report $-0.19 for Q...